News
Puris to launch new H2-IZO pea protein ingredient at IFT FIRST 2026
49+ min ago (216+ words) Advertising" |" About us" |" Meet the team" |" Privacy Puris has announced the upcoming launch of its new pea protein ingredient, H-IZO, at the IFT FIRST 2026 trade show in Chicago, US, this month. According to the company, which offers a range of…...
AZ forges ever-closer ties with China's CSPC Pharma
29+ min ago (501+ words) Astra Zeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new agreement to develop drugs for kidney diseases. Hong Kong-listed CSPC revealed the latest deal with AZ in a stock exchange filing (PDF), noting…...
Pharma's AI Boom Has Bet on the Wrong Bottleneck
15+ hour, 46+ min ago (205+ words) What the money bought Where the value actually is The trouble is that designing the molecule was never the expensive part. The roughly $2. 6 billion it takes to bring a single drug to market is dominated not by discovery but by…...
Scientists create artificial life from chemicals, and it eats, grows, and divides like the real thing
1+ hour, 19+ min ago (118+ words) How data-fogged MCA annual report fails to mirror India Inc's health Stock Radar: Oberoi Realty breaks out of inverse head & shoulder pattern; time to buy? "No doubt Pakistan involved in Pahalgam': Ex-R&AW Chief Ceremonial Reception of Japan PM Sanae…...
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead Bi TAC-TCE Program
1+ hour, 8+ min ago (61+ words) ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA's lead Bi TAC-TCE program toward IND/CTA-enabling activities A new generation of T-cell engagers About VERAXA Biotech AG (NASDAQ: VRXA) Bi TAC…...
Podcast: HLTH Europe and BIO key trends rundown
1+ hour, 35+ min ago (199+ words) Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International Convention. June was a busy month for Pharmaceutical Technology's editorial team, with journalists attending several key conferences with reach across the healthcare and…...
Astra Zeneca signs CSPC China deal for experimental kidney disease drugs
2+ hour, 13+ min ago (156+ words) July 2 (Reuters) " Astra Zeneca has entered into a deal worth up to $1. 77 billion with CSPC "Pharmaceutical Group to discover and "develop experimental medicines with the potential to treat kidney diseases, the Chinese drugmaker said on Thursday. CSPC's Hong Kong stock…...
Top Companies in Viral Vector Manufacturing Market
1+ hour, 56+ min ago (195+ words) Home / Blogs / Viral Vector Manufacturing Industry The main developments affecting the business are the expansion of large scale GMP manufacturing facilities and the development of adeno-associated virus (AAV) and lentiviral vector platforms and automated bioprocessing technologies. Top 7 Leading Vector Manufacturing…...
Halfway into the year, biotech is booming
1+ hour, 56+ min ago (178+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the…...
US launches security probe five pharma giants doing clinical trials in China
2+ hour, 20+ min ago (212+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. US launches security probe five pharma giants doing clinical trials in China MSD, Abb Vie, Eli Lilly, Pfizer, and Bristol Myers Squibb must provide an…...